|
|
|
Industry News
|
••• On this page, you will find new information on issues relevant to vascular disease.
If you have a newsworthy item to submit,
Rebecca Kapur.
Terumo Partners with GHX for More Efficient Electronic Ordering Capabilities
SOMERSET, NJ – Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation (TMC), announces a new partnership between TMC and Global Health Exchange (GHX); expanding its reputation for supplying technologically advanced quality to supply chain management.
Working with GHX and its Electronic Data Interchange (EDI) system, Terumo Interventional Systems is looking to deliver providers what they want—when they want it. Through this e-commerce platform’s unique, streamlined process, hospitals are now easily able to place orders, generate receipts, and change and track orders with Terumo.
Arrow International, Inc., to Provide Hand-Held Ultrasound for Vascular Access
Exclusive agreement with the Esaote Group for the InView™ Hand-Held Ultrasound System paves the way for future product development.
READING, Pa.--(BUSINESS WIRE)--Arrow International (NASDAQ: ARRO), the world’s leading provider of central venous catheter (CVC) products, has announced that it will distribute in the U.S. and Canada on an exclusive basis a new Hand-Held Ultrasound System for vascular access produced by Esaote, a leading worldwide manufacturer of medical diagnostic equipment based in Italy.
ANGIODYNAMICS ANNOUNCES PLAN TO LAUNCH
NEVERTOUCH™ VENACURE® PRODUCT LINE
QUEENSBURY, N.Y. (April 2, 2007) – AngioDynamics, Inc. (NASDAQ: ANGO) announced today plans to launch the NeverTouch VenaCure procedure kit for laser treatment of severe varicose veins. The improved VenaCure design will employ a proprietary laser fiber technology designed to provide an enhanced level of perforation protection by further preventing contact between the fiber tip and the vessel wall during treatment.
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
Cook Medical’s ZILVER PTX Paclitaxel-Eluting Stent (DES) trial results demonstrated no stent fractures. The major adverse event (MAE) rate was equivalent to conventional balloon angioplasty treatment at its six-month follow-up point, as reported by the trial’s national principal investigator.
FilterWire EZ™ Embolic Protection System Cleared by FDA for Cartoid Artery Stenting
Boston Scientific Corporation announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market its FilterWire EZ™ Embolic Protection System for use in carotid artery stenting (CAS) procedures. The device was cleared by the FDA in August 2004 for use in coronary saphenous vein graft (SVG) interventions and is currently the market-leading embolic protection device for carotid artery stenting procedures outside the U.S.
Georgetown University Medical Center First to Implant Patient with GORE PROPATEN Vascular Graft in the U.S. since Its FDA Clearance
W. L. Gore & Associates (GORE) announced that Georgetown University Hospital (GUH) in Washington, D.C. was the site of the first U.S. implant of the GORE PROPATEN Vascular Graft since its FDA clearance earlier this month. During a four-hour operation Richard Neville, M.D., chief of Vascular Surgery, GUH performed a bypass to save a patient's leg from amputation. The GORE PROPATEN Vascular Graft is the first synthetic vascular graft available in the U.S. that is designed to address the clinical problem of thrombotic vascular graft failure.
FDA Clears Possis AngioJet® System for Blood Clot Removal in Veins
Possis Medical, Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its AngioJet® Xpeedior® catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. The Xpeedior catheter, which is used with Possis' world-leading AngioJet System, is the only device cleared for removing thrombus—a treatment known as thrombectomy—in peripheral veins.
|
|
|
|
